Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial
RESET-Myositis I/II期试验中,一名免疫介导性坏死性肌病患者接受CD19 CAR-T疗法的病例研究
期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2024.09.009
Volkov, Jenell; Nunez, Daniel; Mozaffar, Tahseen; Stadanlick, Jason; Werner, Mallorie; Vorndran, Zachary; Ellis, Alexandra; Williams, Jazmean; Cicarelli, Justin; Lam, Quynh; Furmanak, Thomas; Schmitt, Chris; Hadi-Nezhad, Fatemeh; Thompson, Daniel; Miller, Claire; Little, Courtney; Chang, David; Basu, Samik